Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins

Neuregulin-1 (NRG1) is a potential therapeutic agent for the treatment of doxorubicin (Dox)-induced heart failure. NRG1, however, activates the erbB2 receptor, which is frequently overexpressed in breast cancers. It is, therefore, important to understand how NRG1, via erbB2, protects the heart again...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Bian, Yun, Sun, Maoyun, Silver, Marcy, Ho, Kalon K. L., Marchionni, Mark A., Caggiano, Anthony O., Stone, James R., Amende, Ivo, Hampton, Thomas G., Morgan, James P., Yan, Xinhua
格式: Artigo
語言:Inglês
出版: American Physiological Society 2009
主題:
Translational Physiology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2793128/
https://ncbi.nlm.nih.gov/pubmed/19801490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.01010.2008
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍